Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Serina Therapeutics (SER) R&D In Process (2018)

Historic R&D In Process for Serina Therapeutics (SER) over the last 1 years, with Q1 2018 value amounting to $800000.0.

  • Serina Therapeutics' R&D In Process changed N/A to $800000.0 in Q1 2018 from the same period last year, while for Dec 2018 it was $800000.0, marking a year-over-year change of. This contributed to the annual value of $800000.0 for FY2018, which is N/A changed from last year.
  • According to the latest figures from Q1 2018, Serina Therapeutics' R&D In Process is $800000.0.
  • In the past 5 years, Serina Therapeutics' R&D In Process registered a high of $800000.0 during Q1 2018, and its lowest value of $800000.0 during Q1 2018.